Our system has noticed that you are based in , but the current country setting is . Select country
-
Jul 28, 2022Read more
WACKER Raises Full-Year Forecast after Another Strong Quarter
-
Jun 07, 2022Read more
mk2 Biotechnologies, WACKER and TUM jointly develop a process for the large-scale production of antimicrobial peptides based on sustainable fermentation
-
May 20, 2022Read more
Annual Shareholders’ Meeting Approves Record Dividend
-
Apr 28, 2022Read more
WACKER achieves sales above €2 billion for the first time in Q1 2022 and more than doubles EBITDA year over year
-
Apr 11, 2022Read more
Pandemic Preparedness: WACKER and CordenPharma Will Produce mRNA Vaccines for Germany When Needed